ICPT - Intercept Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52.87B
Enterprise Value 32.58B
Trailing P/E N/A
Forward P/E 1-10.01
PEG Ratio (5 yr expected) 10.90
Price/Sales (ttm)14.63
Price/Book (mrq)N/A
Enterprise Value/Revenue 313.18
Enterprise Value/EBITDA 6-8.96

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin -162.13%
Operating Margin (ttm)-149.92%

Management Effectiveness

Return on Assets (ttm)-44.16%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)196.09M
Revenue Per Share (ttm)6.63
Quarterly Revenue Growth (yoy)45.30%
Gross Profit (ttm)177.28M
EBITDA -288.29M
Net Income Avi to Common (ttm)-317.92M
Diluted EPS (ttm)-10.75
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)353.54M
Total Cash Per Share (mrq)11.87
Total Debt (mrq)391.21M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.72
Book Value Per Share (mrq)-1.85

Cash Flow Statement

Operating Cash Flow (ttm)-235.27M
Levered Free Cash Flow (ttm)-119.04M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.56
52-Week Change 320.86%
S&P500 52-Week Change 34.92%
52 Week High 3133.74
52 Week Low 365.63
50-Day Moving Average 391.30
200-Day Moving Average 3103.69

Share Statistics

Avg Vol (3 month) 3901.33k
Avg Vol (10 day) 3511.41k
Shares Outstanding 532.67M
Float 23.51M
% Held by Insiders 124.22%
% Held by Institutions 172.67%
Shares Short (Apr 30, 2019) 45.26M
Short Ratio (Apr 30, 2019) 44.8
Short % of Float (Apr 30, 2019) 428.76%
Short % of Shares Outstanding (Apr 30, 2019) 417.65%
Shares Short (prior month Mar 29, 2019) 44.4M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A